Noam Gottesman’s Top Stock Picks Include Facebook Inc (FB)

Page 1 of 2

We have been working on analyzing the latest round of 13F filings from hedge funds and other notable investors. These documents disclose many of a filer’s long equity positions in U.S. stocks as of the end of the most recent quarter (December in this case). We have found that even with the lag in reporting the public can still use this information in a few different ways. For one, the most popular small cap stocks among hedge funds outperform the S&P 500 by 18 percentage points per year on average and other investment strategies are possible as well (read more about imitating hedge funds’ stock picks). Another way to use 13F filings is to use top picks by fund managers as free recommendations. Just as with any other source of ideas it’s important to evaluate these investments on their own merits. Here are Noam Gottesman and GLG Partners’ five largest single-stock equity holdings according to the 13F:

GLG increased its stake in VMware, Inc. (NYSE:VMW) to a total of about 840,000 shares. VMware’s software products and solutions are focused on cloud computing. Its stock price has fallen 28% in the last year and 14% of the outstanding shares remain short, as earnings growth has been low recently even while sales have been quite strong. At a trailing earnings multiple of 42 VMware will have to start generating earnings growth very soon in order to justify its valuation. Billionaire Steve Cohen’s SAC Capital Advisors was buying shares of VMware in Q4 (see Cohen’s stock picks).

Facebook Inc (FB), JetBlue Airways Corporation (JBLU)

Another growth stock that Gottesman and his team were buying last quarter was Facebook Inc (NASDAQ:FB) – they had 2.2 million shares at the end of December per the 13F. Facebook Inc (NASDAQ:FB) was one of the most popular tech stocks among hedge funds in the fourth quarter of 2012 (find more tech stocks hedge funds love) despite the fact that its forward earnings multiple- based on estimates for 2014- is 35. While Facebook Inc (NASDAQ:FB) has been experiencing high revenue growth it has been accompanied by high costs and it is unclear to us that it can become as profitable as investors believe.

Learn about more of GLG’s top stock picks:

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!